About Edimer

Edimer Pharmaceuticals, Inc. is a US-based biotechnology company in Cambridge, Massachusetts. Edimer is dedicated to improving the lives of future generations living with X-linked hypohidrotic ectodermal dysplasia (XLHED).

In June 2012, Edimer Pharmaceuticals received fast-track designation from the US Food and Drug Administration (FDA) for EDI200, the company's novel and innovative treatment for XLHED. EDI200 is the first of a new class of drugs designed to treat XLHED with a lifelong effect by correcting the genetic defect responsible for XLHED. If you are interested in learning more about Edimer's clinical trials, please visit www.clinicaltrials.gov.

For further information on Edimer Pharmaceuticals or EDI200, visit www.edimerpharma.com. To receive updates about Edimer Pharmaceuticals' progress in developing a treatment for XLHED, please join the XLHED Network. You'll stay informed on local events and important news.

Join now.

Contact Us

Edimer Pharmaceuticals
55 Cambridge Parkway, Suite 102W
Cambridge, MA 02142
Tel: +1 617-758-4300
Fax: +1 866-334-4240

Get free genetic testing

Find out if you are a carrier for XLHED with FREE genetic testing. All you have to do is join the XLHED Network. You will be sent an e-mail if you are a candidate for testing. Please note that the genetic analysis is free, but you will be responsible for other costs related to the testing. These costs may include, for example, the doctor's office visit and having your blood taken. It's another important reason for you to join the XLHED Network today.